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ABSTRACT
The extent to which childhood GHD affects adult fracture risk is unclear. We measured femoral strength in
adult transgenic growth–retarded rats as a model of GHD. Long-term, moderate GHD was accompanied by
endocrine and morphometric changes consistent with a significant reduction in femoral strength.
Introduction: Childhood growth hormone deficiency (GHD) is associated with osteopenia, but little is known about
its effects on subsequent adult bone strength and fracture risk.
Materials and Methods: We have therefore measured femoral strength (failure load measured by three-point
bending) in a new model of moderate GHD, the transgenic growth–retarded (Tgr) rat at 15, 22–23, and 52 weeks of
age, and have quantified potential morphological and endocrine determinants of bone strength.
Results: Skeletal growth retardation in Tgr rats was accompanied by a sustained reduction in the anterior-posterior
diameter of the femoral cortex, whereas mid-diaphyseal cortical wall thicknesses were largely unaltered. Total femoral
strength was significantly impaired in Tgr rats (p  0.01), and this impairment was more pronounced in males than
females. Compromised bone strength in Tgr rats could not be accounted for by the reduction in mechanical load (body
weight) and was not caused by impairment of the material properties of the calcified tissue (ultimate tensile stress), despite
marked reductions in femoral mineral density (areal bone mineral density; p  0.001). Microcomputerized tomographical
analysis revealed significant modification of the architecture of trabecular bone in Tgr rats, with reductions in the number
and thickness of trabeculae (p  0.05) and in the degree of anisotropy (p  0.01). The marked reduction in plasma
insulin-like growth factor-1 in Tgr rats was accompanied by the development of high circulating leptin levels (p  0.01).
Conclusion: These results show that the changes in endocrinology and bone morphology associated with long-term
moderate GHD in Tgr rats are accompanied by changes consistent with a significant reduction in the threshold for
femoral fracture.
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INTRODUCTION
GROWTH HORMONE (GH) is the primary regulator of post-natal longitudinal bone growth in mammals and also
contributes to the humoral control of bone mineraliza-
tion.(1,2) In humans, adult-onset GH deficiency (GHD) leads
to impairment of bone mineral density (BMD)(3) and an
increased fracture risk.(4) Childhood GHD, which is often
diagnosed with less stringent criteria,(5–7) is also associated
with impaired bone mineral accumulation and turnover,(8,9)
and if uncorrected through puberty, may result in reduced
peak bone mass in young adult life.(10,11) The extent to
which failure to achieve adequate peak bone mass in late
adolescence and early adulthood leads to an increased risk
of subsequent osteoporosis and bone fracture remains un-
clear.(12)
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Because many of the processes of bone growth and re-
modeling are similar in rats and humans,(13) we have used a
new model of moderate GHD, the transgenic growth–
retarded (Tgr) rat, to examine the effects of reduced circu-
lating GH on bone strength. In this model, expression of
human (h)GH in the arcuate GH-releasing factor neurons
causes a 60% reduction in pituitary GH content and a 50%
reduction in the amplitude of the episodes of GH secre-
tion.(14,15) This represents a similar degree of GHD to that
seen most frequently in childhood-onset GHD patients and
may represent a more appropriate model for analysis of
bone strength in this context than the more profoundly
deficient dw/dw rat.(16)
In the studies reported here, we describe the development
of impaired femoral strength with age in both male and
female Tgr rats, relating total bone and material strength
with endocrine, morphometric, and mineral density param-
eters. In addition, to overcome the limitations related to
measurement of areal mineral density, we used microcom-
puterized tomographical (micro-CT) scanning to analyze
bone density and describe modifications in trabecular archi-
tecture in the Tgr model of GHD.
MATERIALS AND METHODS
Tgr rats
The animal procedures described conformed to the insti-
tutional and national ethical guidelines for experiments with
genetically modified rats. Hemizygous Tgr rats and normal
wild-type (WT) littermates were derived from the original
colony at the National Institute for Medical Research (Lon-
don, UK) and bred in the Transgenic Unit (School of
Biosciences, Cardiff University). All animals were housed
under conditions of 14-h light:10-h dark (lights on at 5:00
a.m.), with food (Harlan Teklad Rodent Maintenance Diet,
Harlan, UK; nutritional composition: protein 14.2%; oil
4.9%; calcium 0.6%; sodium 0.25%; potassium 0.39%;
phosphorous 0.32%; chloride 0.52%) and water available ad
libitum.
Skeletal growth and weight gain in Tgr rats
Groups of nonfasting 15-, 22–23-, and 52-week-old male
and female WT and Tgr rats (n  4–6) from the Cardiff
colony were weighed and killed. Trunk blood was collected,
and separated plasma was stored at 20°C for subsequent
determination of insulin-like growth factor-1 (IGF-1) and
leptin concentrations. Left femurs were dissected, total
length was measured with a hand-held micrometer, and the
femurs were wrapped in sterile saline gauze and stored at
20°C before measurements of bone mineral content
(BMC), strength and morphology, and trabecular organiza-
tion.
Femoral mineralization in Tgr rats
Bone mineral content (BMC) was measured by DXA
using the Lunar Pixi small animal scanner. The accuracy of
this technique in measuring calcium content was confirmed
in preliminary studies, in which a highly significant corre-
lation between femoral total BMC and ash weight (r  0.86;
p  0.0001) was obtained.(17) The CV for femoral BMD for
five repeated scans of 30 femurs, with repositioning be-
tween scans, was 2.7%. Bones were thawed at room tem-
perature for 30 minutes before measurement and aligned
anterior-posteriorly relative to the scanning beam. Measure-
ments of total BMC (g) and scanned bone area (BA; cm2)
were made, and areal BMD (aBMD; g/cm2) was calculated
as BMC/BA. In addition, femoral neck and distal femur
aBMD were determined by measuring BMC in a fixed area
(0.03 cm2) of each region of interest.
Femoral strength and morphology in Tgr rats
Previously frozen left femurs were thawed at room tem-
perature, but only removed from their container just before
mechanical testing to maintain moisture content. The bones
were loaded in three-point bending between 10 mm diam-
eter rollers (16 mm apart), with the middle roller 8 mm from
the outer rollers and positioned over the thinnest part of the
femoral shaft, level with the distal end of the lateral ridge
that runs along the proximal part of the femur toward the
greater trochanter. The posterior aspect of the condyles
rested on the side of the outer roller, and the bones were
orientated such that they were loaded in a roughly posterior
direction. Each bone was loaded at a crosshead speed of 2
mm/minute until failure, with load and displacement data
recorded by the computer controlled testing machine (Lloyd
LRX tensile testing machine with 100N load cell; Lloyd
Instruments, Segensworth, Hants, UK).
Mid-diaphyseal cortical medio-lateral (M-L) and ante-
rior posterior (A-P) diameters, and lateral, medial, an-
terior, and posterior wall thicknesses were measured at
the fracture site using a Vickers microscope and mi-
crometer stage. Using these measurements and simple
beam theory, ultimate tensile stress (UTS) was calcu-
lated using:
 My/I
where the bending moment, M, is one-half the applied
load multiplied by the distance from the central sup-
port, y is one-half the outside depth, and the second
moment of area, I, is given by:
I

64 bodo
3  bidi3
where b and d are the breadth and depth of the cross-
section, respectively, and the subscripts o and i indicate
the inside and outside dimensions, respectively.
Trabecular organization in Tgr rats
Bones were scanned with a commercially available high-
resolution microcomputerized tomography (micro-CT) sys-
tem (CT-40; Scanco Medical, Basserdorf, Switzerland).
Using this system, three-dimensional (3-D) information is
obtained by stacking successively measured slices on top of
each other. No sample preparation is required, and because
the procedure is nondestructive, the bones remain available
for other examination techniques. The chosen voxel size
was 12 m in all three spatial dimensions, and for each
sample, 178 slices were measured. 3-D visualizations of
complete measurements from femurs from WT and Tgr
animals are shown in Figs. 5A and 5B.
1309BONE STRENGTH IN Tgr RATS
The trabecular and the cortical part of each distal femur
were separated with semi-automatically drawn contours.(18)
The complete secondary spongiosa could then be evaluated,
and sampling errors brought by random deviations of single
section were avoided. The resulting grayscale images were
segmented using a low-pass filter to remove noise and a
fixed threshold to extract the mineralized bone phase. From
the binarized images, structural indices of the appearance of
trabecular bone were assessed with recently developed 3-D
techniques without model assumptions. Relative bone vol-
ume and the number, thickness, and separation of the tra-
beculae were calculated by measuring 3-D distances(19)
directly in the trabecular network and taking the mean over
all voxels. The diameter of spheres filling the structure was
taken as trabecular thickness, the thickness of the marrow
spaces as trabecular separation, and the inverse of the mean
distances of the mineralized structure was calculated as
trabecular number. Degree of anisotropy was determined
using a 3-D method similar to the mean intercept length
(MIL),(18) and was taken as the ratio of the biggest MIL
divided by the smallest MIL (i.e., a degree of anisoptropy of
1.0 denotes an isotropic structure).
Plasma IGF-1 and leptin concentrations in Tgr rats
Plasma IGF-1 and leptin concentrations were determined
by radioimmunoassay (RIA; Immunodiagnostic Systems
Ltd., Boldon, UK and Linco Research Inc., St Charles, MO,
USA, respectively). The mean inter- and intra-assay CVs
for these assays were 5.7% and 4.1–9.4% (IGF-1) and
3.0–5.7% and 2.0–4.6% (leptin), respectively.
Statistical analysis
All data are expressed as mean  SE, with statistical
comparisons being performed by Student’s t-test or
ANOVA plus Bonferroni/Dunnett’s post hoc test as appro-
priate.
RESULTS
Skeletal growth and weight gain in Tgr rats
At the end of the rapid growth phase (15–23 weeks), the
lower body weights in Tgr rats (Fig. 1A; 30% less in males,
20% less in females; p  0.001) were accompanied by
significantly shorter femoral lengths (Fig. 1B; 13% less in
males, 9% less in females; p  0.001). During the slower
phase of growth (23–52 weeks), body weights in Tgr rats
continued to increase at a higher rate than that of their WT
littermates (p  0.001), whereas femoral length increased
(p  0.05) in Tgr rats parallel with their WT counterparts.
This higher rate of body weight gain may be accounted for,
in part, by increased adiposity in Tgr rats, visceral fat depots
being proportionately larger in Tgr rats than in their WT
littermates (p  0.01; data not shown).
Femoral mineralization in Tgr rats
Total femoral BMC and aBMD increased rapidly in WT
males between 15 and 22 weeks (Figs. 2A and 2B; p 
0.01), but remained unaltered thereafter. Total femoral
BMC and aBMD were markedly lower in Tgr males (BMC
40% less; aBMD 20% less; p  0.001), but the same
developmental pattern was observed. Total femoral BMC
continued to rise with age in WT females (p  0.05) and
remained 30% lower than that in WT males (p  0.01).
However, total femoral aBMD was only significantly dif-
ferent between WT males and WT females in 22- to 23-
week-old rats (p  0.001). Femoral BMC and aBMD in Tgr
females were significantly lower than WT females at all
ages (BMC 30% less; aBMD 18% less; p  0.001), increas-
ing significantly between 23 and 52 weeks (p  0.01). In
comparison with Tgr males, femoral BMC in Tgr females
was significantly lower at both 22–23 weeks and at 52
weeks (p  0.001), but was only reflected in a significant
difference in aBMD at 22–23 weeks (p  0.001).
Analysis of aBMD in different regions revealed that in
the femoral neck aBMD increased continuously with age in
all groups, showing a 60–80% increase from 15 to 52
weeks (Fig. 2C; p  0.001). In contrast, aBMD in the distal
femur showed a small decline from 15 to 22 weeks in all but
the Tgr males (Fig. 2D; p  0.05), increasing in all groups
from 22 to 52 weeks (p  0.01) to produce a small (15%)
overall elevation (15–52 weeks) in all but the WT females
(p  0.05). In Tgr rats, aBMD was significantly lower in the
trabecular neck region of the femur at 52 weeks (15–25%
less; p  0.01) and was significantly reduced at all ages in
the distal femur (Fig. 2D; 16–24% less; p  0.001). There
was no observable sexual dimorphism in aBMD in either
neck or distal portions of the femur.
Femoral strength and morphology in Tgr rats
Morphometric analysis of the fracture site after strength
testing (discussed below) revealed that mid-diaphyseal cor-
FIG. 1. Developmental growth changes in
male (squares) and female (circles) WT (open
symbols) and Tgr (closed symbols) rats. Param-
eters shown are (A) body weight and (B) femoral
length. Values shown are mean  SE (n  4–6;
and statistical comparisons described in the text
made using one-way ANOVA and Bonferroni
comparison).
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tical A-P diameters in 15-week-old male Tgr rats were 20%
smaller than in WT males (Figs. 3A and 3B; p  0.001).
This difference (p  0.01) was less pronounced (10%) in
females. A-P diameters did not change with age. At 15
weeks of age, mid-diaphyseal cortical M-L diameters were
significantly greater in WT males than in any other group
(p  0.001) and had increased steeply by 22 weeks (p 
0.001). By 1 year, mid-diaphyseal cortical M-L diameters
had converged in all groups. The sex-dependent differences
in femoral diameter in WT rats were not observed in Tgr
animals. The pattern of age-dependent changes in lateral
and medial mid-diaphyseal cortical wall thicknesses was
most pronounced in Tgr rats (Figs. 3E and 3F). Between 15
and 22–23 weeks, lateral wall thickness decreased rapidly in
male (p  0.05) and female (p  0.01) Tgr rats, while
medial wall thickness increased steeply over the same pe-
riod (males, p  0.01; females, p  0.001). This pattern was
not statistically significant in WT animals. There were no
significant differences in mid-diaphyseal cortical anterior
and posterior wall thicknesses between the groups, and
these parameters did not change with age (Figs. 3C and 3D).
Cortical femoral strength was assessed by two methods:
direct measurement of failure load, indicating the strength
of the whole bone, and calculation of UTS, an index of the
strength of the calcified tissue per se. Although failure load
was similar in male and female WT rats at 15 weeks, total
bone strength diverged thereafter because of a large (33%)
and sustained elevation in failure load in WT males at 22
weeks (Fig. 4A; p  0.001). This rapid rise in failure load
was not seen in Tgr males, which remained significantly
weaker than their WT littermates at all ages (p  0.01) and
similar to their female Tgr littermates. These differences in
failure load were not reflected in parallel changes in UTS.
Indeed, at 15 weeks, UTS was 25% lower in WT males than
any other group (Fig. 4B; p  0.001). In Tgr males, UTS
decreased by 20% between 15 and 22 weeks, at which age
there was a clear sexual dimorphism in the mechanical
properties of the calcified material in both strains (p 
0.05). UTS subsequently converged in all groups.
Regression analysis revealed that failure load was posi-
tively correlated with body weight in WT males (r2  0.86;
Fig. 4C). This relationship was disrupted in Tgr males (r2 
0.10) and was not observed in either group of female rats.
UTS was not correlated with body weight in any group (data
not shown). Adjustment of failure load to correct for the
influence of body weight demonstrated that, after the rapid
growth phase, Tgr males had significantly weaker bones on
a per gram body weight basis than any other group (p 
0.01; Fig. 4D).
Trabecular organization in Tgr rats
Micro-CT analysis of the trabecular region of a subgroup
of femurs from 15-week-old males revealed that femurs
from Tgr rats had 32% less calcified tissue per unit volume
(relative bone density) than WT males (p  0.01; Table 1 ;
Fig. 5). This was due primarily to a lower number of
trabeculae (connectivity density; 19% less; p  0.05), with
a smaller reduction in trabecular thickness (11% thinner;
p  0.05) and a corresponding increase in trabecular sepa-
ration (p  0.01). In addition, trabeculae from Tgr rats had
a significantly greater intra-individual range of thicknesses
than those in WT femurs (p  0.05; data not shown), and
FIG. 2. The development of femoral mineral-
ization in male (squares) and female (circles)
WT (open symbols) and Tgr (closed symbols)
rats. Parameters shown are (A) total femoral
BMC, (B) total femoral aBMD, (C) femoral
neck aBMD, and (D) distal femur aBMD. Val-
ues shown are mean  SE (n  4–6; and
statistical comparisons described in the text
made using one-way ANOVA and Bonferroni
comparison).
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the degree of trabecular anisotropy (an index of trabecular
orientation) was significantly lower in femurs from Tgr rats
(p  0.01), indicating that the main axial direction is less
pronounced in this model. Analysis of cortical bone from
the distal femur showed little difference between WT and
Tgr rats (data not shown).
Plasma IGF-1 and leptin concentrations in Tgr rats
Circulating IGF-1 declined with age in all groups but
remained 4- to 7-fold higher in WT than Tgr males (Fig. 6A;
p  0.001). This difference was less pronounced in females,
with plasma IGF-1 concentrations in 1-year-old Tgr rats
being similar to their WT littermates (Fig. 6A). Plasma
leptin concentrations remained largely unaltered in WT rats,
with a small increase (p  0.05) in WT females between 23
and 52 weeks (Fig. 6B). However, at 15 weeks, circulating
leptin levels in Tgr males were 2-fold higher than all other
groups (p  0.001) and continued to rise steeply, remaining
3- to 4-fold higher than their WT counterparts at both 22
weeks (p  0.01) and 1 year (p  0.001). Plasma leptin
concentration in Tgr females also rose steeply, in parallel
with Tgr males and were double that of female WT litter-
mates at 23 (p  0.01) and 52 weeks (p  0.001).
DISCUSSION
The regulation of cortical bone strength is achieved by a
complex interaction between endocrine and mechanical fac-
tors controlling bone morphology and mineralization. As
the principle endocrine regulator of postnatal longitudinal
bone growth in mammals, GH is thought to act both directly
through GH receptors in bone(20,21) and indirectly through
stimulation of the endocrine and paracrine actions of
IGF-1.(22) However, the influence of early onset GHD on
bone strength in adulthood remains unclear. Although rats
retain open epiphyseal growth plates into adulthood and are
FIG. 3. The development of femoral morphol-
ogy in male (squares) and female (circles) WT
(open symbols) and Tgr (closed symbols) rats.
Parameters shown are (A) mid-diaphyseal corti-
cal anterior-posterior diameter (A-PØ), (B) mid-
diaphyseal cortical medio-lateral diameter (M-
LØ), and (C) anterior, (D) posterior, (E) lateral,
and (F) medial mid-diaphyseal cortical wall
thicknesses. Values shown are mean  SE (n 
4–6; and statistical comparisons described in the
text made using one-way ANOVA and Bonfer-
roni comparison).
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not thought to undergo intracortical remodeling,(23) many of
the processes of bone growth are similar to those in hu-
mans.(13) We have, therefore, used a new model of moderate
GHD, the Tgr rat, to investigate the potential contribution of
GH to the determinants of bone strength in early adulthood.
Our results indicate that GH is a significant determinant
of bone strength, with a greater reduction in total femoral
failure load in male Tgr rats (Fig. 4A) accompanying the
greater degree of GHD in this sex.(15) The effect of GH on
bone strength does not seem to be mediated by its influence
on body weight and the consequent alteration of load. In-
deed, the relationship between body weight and failure load
seen in normal male rats is disrupted in the Tgr model (Fig.
4C).
Bone strength is clearly related to bone size.(24) In the Tgr
model, the reduction in femoral length is accompanied by a
sustained reduction in the external dimensions of the corti-
cal bone, in particular the mid-diaphyseal cortical A-P di-
ameter. Because failure load was determined by loading the
bones in a posterior direction, the A-P diameter will have a
greater impact on bone strength than the initial reduction in
M-L diameter. In bending, the relationship between the
tensile stresses produced and the distance from the neutral
surface is approximately linear. Thus, the anterior and pos-
terior surfaces carry high compressive and tensile stresses,
respectively, while the medial and lateral surfaces bear only
relatively small shear stresses. Cortical wall thickness, on
the other hand, is not affected by the reduction in circulating
GH in this model.
In addition to femoral geometry, the quality of bone
tissue is an important determinant of strength.(24) It was
therefore surprising that, given the clearly observable dif-
ferences in total femoral BMC and aBMD, calculation of
UTS revealed that after the rapid growth phase, the strength
of the calcified tissue in Tgr rats was not significantly
different. There may be a number of reasons for the disrup-
tion in the relationship between UTS and our measurements
of femoral mineralization. First, tensile strength was only
determined in the mid-diaphyseal cortex, whereas the mea-
surements of BMD include the trabecular bone in the me-
taphyses. Second, using an areal technique to assess total
femoral BMD only partially corrects for bone size,(25,26) and
may not produce an accurate representation of volumetric
BMD at the cortical site of fracture. It should also be noted
that the UTS values obtained in this study are somewhat
higher than previously reported values for cortical bone in
larger mammals.(23,27) This may be accounted for by the
different microstructure of cortical bone in rats and other
small mammals. Rat cortical bone lacks both haversian
systems and the weak points provided by the interconnect-
ing cement lines and also exhibits little or no remodeling.(23)
The observation that UTSs are similar in Tgr and WT rats
suggests that, after the rapid growth phase at least, GH does
not have a significant impact on bone strength through its
regulation of mineralization. This may not be so during the
period of rapid growth. At 15 weeks, the earliest age mea-
sured in this study, UTS is, paradoxically, lower in WT
males, which may be due, in part, to an increased rate of
modeling/remodeling in this more rapidly growing cohort.
As the growth rate slows in WT males between 15 and 22
weeks, there is a gradual increase in UTS. Conversely, the
sharp decrease in UTS seen in Tgr males from 15 to 22
weeks may contribute to the declining failure load over the
same period. The factors contributing to this decline are
discussed below.
FIG. 4. The development of femoral strength
in male (squares) and female (circles) WT (open
symbols) and Tgr (closed symbols) rats. Param-
eters shown are (A) failure load, (B) ultimate
tensile stress, (C) regression analysis of failure
load and body weight, and (D) the effect of
adjustment of failure load for body weight. Val-
ues shown are mean  SE (n  4–6; and
statistical comparisons described in the text
made using one-way ANOVA and Bonferroni or
Dunnett’s comparison as appropriate).
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While changes in trabecular microachitecture are unlikely
to contribute to the reduction in cortical strength in the Tgr
rat, such alterations provide a helpful insight into the pro-
cess of remodeling. The combination of fewer trabeculae
with greater heterogeneity of trabecular thickness and less
pronounced main axial direction indicates that, in the con-
text of moderate GHD, the control of trabecular organiza-
tion is altered. A reduction in tibial trabecular bone volume
has previously been reported for the profoundly GHD
dw/dw rat.(28) The presence of smaller numbers of more
widely spaced trabeculae in GHD rats is consistent with
remodeling simulations,(29,30) predicting that resorption re-
sults in loss of trabeculae even with subsequent bone dep-
osition. Should new bone deposition be inhibited, not only
would trabecular number remain reduced, but the positive
correlation between external load (body weight) and bone
strength will be disrupted. This is the case in Tgr males,
where the positive correlation between body weight and
failure load seen in WT males is absent (Fig. 4C).
Thus, the influence of GH on femoral strength seems to
be caused by its effects on bone size rather than on bone
quality. Similar findings have been reported for MT-GH-
transgenic mice with elevated circulating GH concentra-
tions, in which increased mechanical strength is associated
with increased cortical width(31,32) and also in 2-year-old
male rats treated with hGH for up to 80 days.(33) However,
our experiments do not distinguish between the direct ef-
fects of GH and those mediated by IGF-1. The results
reported here confirm that circulating IGF-1 concentrations
are profoundly reduced in this model,(15) and show that, as
with their WT littermates, IGF-1 production declines with
age (Fig. 6A). However, these measurements may not pro-
vide an accurate reflection of IGF-1 bioavailability. This is
influenced by the circulating IGF-binding proteins, which
FIG. 5. Micro-CT 3-D recon-
structions of trabecular structure
in distal femur from (A) WT and
(B) Tgr male femurs. Each image
represents an anterior-posterior
cross-section through the distal
femur adjacent to the growth
plate, viewing the trabecular or-
ganization from the growth plate
toward the shaft. The reduction in
trabecular number and increase in
trabecular separation that give
rise to the reduction in relative
bone density in Tgr rats (Table 1)
are clearly observable in these
images.
FIG. 6. Developmental changes in endocrinol-
ogy in male (squares) and female (circles) WT
(open symbols) and Tgr (closed symbols) rats.
Parameters shown are (A) plasma IGF-1 concen-
tration and (B) plasma leptin concentration. Val-
ues shown are mean  SE (n  4–6; and
statistical comparisons described in the text
made using one-way ANOVA and Bonferroni
comparison).
TABLE 1. TRABECULAR STRUCTURE IN 15-WEEK-OLD WT AND Tgr MALE RATS
Relative bone density
(%)
Connectivity density
(connections/mm3)
Trabecular thickness
(mm)
Trabecular separation
(mm)
Trabecular orientation
(degree of anisotropy)
Wild-type male 20.83  1.05 83.26  2.89 0.0842  0.0019 0.298  0.018 1.704  0.024
Tgr male 14.12  1.04† 67.69  3.74* 0.0753  0.0024* 0.400  0.009† 1.453  0.026†
Values shown are mean  SE (n  3; statistical comparisons made using Student’s t-test).
* p  0.05.
† p  0.01.
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were not measured in this study. In growing children cir-
culating IGF-1 is a major determinant of the cross-sectional
morphology of the femur, but has no influence on the
material density of cortical bone.(34)
The development of elevated circulating leptin concen-
trations in the Tgr rat is an important new observation in the
context of the reported influences of this hormone on
bone.(35,36) The steep rise in circulating leptin seen in Tgr
rats is likely to relate to the increased visceral fat deposition
in this model (our unpublished data), which may contribute
to the converging body weights when there is no corre-
sponding convergence in skeletal size. Thus, the increased
contribution of fat deposition to body weight and the result-
ant elevation in circulating leptin may contribute to the
disruption of the relationship between body weight and
failure load.
It is now thought that leptin has a range of actions on
bone,(37) although some of the published findings appear to
be conflicting. For example, while leptin stimulates bone
growth in ob/ob mice,(36) it also inhibits bone formation.(35)
It is proposed that this latter action involves a hypothalamic
component.(35) However, the high levels of leptin expres-
sion in bone marrow adipocytes,(38) and the action of leptin
to favor the differentiation of marrow stromal cells into
osteoblasts rather than adipocytes in vitro,(39) suggest an
autocrine/paracrine action for leptin. Thus, the development
of elevated circulating leptin concentrations in Tgr rats may
have a profound impact on the factors regulating bone
strength in this model, particularly if the mechanism favor-
ing elevated visceral adiposity and circulating leptin en-
hances adipogenesis and leptin expression in marrow. It is
possible that the steep rise in circulating leptin concentra-
tion contributes to the observed decline in strength of both
the calcified material (UTS; Fig. 4B) and the whole femur
(failure load; Fig. 4A) between 15 and 22 weeks in male Tgr
rats, particularly in the context of an 85% reduction in
circulating IGF-1. This effect of leptin may be obscured in
Tgr females by the presence of higher levels of circulating
GH.(15)
The possible impact of leptin on the endocrine control of
the bone microenvironment in this model has implications
for the potential therapeutic modalities used to accelerate
skeletal growth. A unique feature of the Tgr model of
dwarfism is that the residual responsiveness of the
hypothalamo-pituitary GH axis to treatment with the GH
secretagogues (GHSs)(15) is sufficient to accelerate skeletal
growth.(40) However, it is now clear that ghrelin, the endog-
enous ligand for the GHS receptor,(41) induces adiposity in
the context of GHD.(42) While we are currently investigat-
ing the adipogenic effect of the GHSs in the Tgr model,
these findings suggest that optimal growth recovery may be
obtained with more conventional GH replacement.
In summary, the Tgr rat is a model of moderate GHD, in
which reduced plasma IGF-1 and increased circulating lep-
tin are accompanied by a profound reduction in femoral
strength. The weakness of the femoral cortex appears to be
more closely related to femoral diameter than to the material
properties of the calcified tissue. The disruption of the
relationship between body weight and failure load in this
model indicates that the effect of GH on bone strength is not
mediated by its influence on body weight. In addition, these
results suggest that patients with moderate childhood onset
GHD may have an increased risk of fracture if left untreated
during their growth phase and that fracture risk may be
further increased if GHD is accompanied by elevated adi-
posity.
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